Clinical Trial Update: Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Cetaphil Advanced Usage to control light-to-moderate atopic dermatitis and reduce the need for topical corticosteroids; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cetaphil Advanced Usage (cetaphil)

Snippet

Sponsor: Galderma Brasil Ltda. | Conditions: Dermatitis, Atopic | Phase 4 | Status: COMPLETED